Literature DB >> 27804276

Impact of disease duration and cardiovascular dysautonomia on hypertension in Parkinson's disease.

Davide L Vetrano1,2, Maria S Pisciotta2, Vincenzo Brandi2, Maria R Lo Monaco2, Alice Laudisio3, Graziano Onder2, Domenico Fusco2, Paolo D L'Angiocola4, Anna R Bentivoglio5,6, Roberto Bernabei2, Giuseppe Zuccalà2.   

Abstract

The authors evaluated the association of Parkinson's disease (PD) duration with hypertension, assessed by office measurements and 24-hour (ambulatory) monitoring, in 167 patients. Hypertension was evaluated through both office and ambulatory blood pressure (BP) measurements. Among participants (mean age 73.4±7.6 years; 35% women), the prevalence of hypertension was 60% and 69% according to office and ambulatory BP measurements, respectively (Cohen's k=0.61; P<.001). PD duration was inversely associated with hypertension as diagnosed by office measurements (odds ratio [OR], 0.92; 95% confidence interval [CI], 0.86-0.98) but not by ambulatory monitoring (OR, 0.94; 95% CI, 0.81-1.01). Ambulatory BP patterns showed higher nocturnal BP among patients with long-lasting disease. In conclusion, ambulatory BP monitoring improves the detection of hypertension by 15% in PD, compared with office evaluation. The likelihood of having hypertension does not decrease during the PD course; rather, BP pattern shifts towards nocturnal hypertension. ©2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Parkinson′s disease; ambulatory blood pressure monitoring; dysautonomia; hypertension; non-motor symptoms

Mesh:

Year:  2016        PMID: 27804276      PMCID: PMC8031361          DOI: 10.1111/jch.12938

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  28 in total

1.  Case-control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan.

Authors:  Yoshihiro Miyake; Keiko Tanaka; Wakaba Fukushima; Satoshi Sasaki; Chikako Kiyohara; Yoshio Tsuboi; Tatsuo Yamada; Tomoko Oeda; Takami Miki; Nobutoshi Kawamura; Nobutaka Sakae; Hidenao Fukuyama; Yoshio Hirota; Masaki Nagai
Journal:  J Neurol Sci       Date:  2010-03-29       Impact factor: 3.181

2.  Clinical characteristics of Parkinson's disease patients in Greece: a multicenter, nation-wide, cross-sectional study.

Authors:  Spiridon Konitsiotis; Sevasti Bostantjopoulou; Maria Chondrogiorgi; Zoe Katsarou; Georgios Tagaris; Ioannis Mavromatis; Evangelia E Ntzani; Georgios Mentenopoulos
Journal:  J Neurol Sci       Date:  2014-05-11       Impact factor: 3.181

Review 3.  The contribution of white matter lesions (WML) to Parkinson's disease cognitive impairment symptoms: A critical review of the literature.

Authors:  Branislav Veselý; Ivan Rektor
Journal:  Parkinsonism Relat Disord       Date:  2015-09-05       Impact factor: 4.891

Review 4.  Dysautonomia in Parkinson disease.

Authors:  David S Goldstein
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

Review 5.  Nicotine as a potential neuroprotective agent for Parkinson's disease.

Authors:  Maryka Quik; Xiomara A Perez; Tanuja Bordia
Journal:  Mov Disord       Date:  2012-06-12       Impact factor: 10.338

6.  The Norwegian office-, home-, and ambulatory blood pressure study (NOHA).

Authors:  Per Omvik; Gerhard Gerhardsen
Journal:  Blood Press       Date:  2003       Impact factor: 2.835

7.  Prospective study on the components of metabolic syndrome and the incidence of Parkinson's disease.

Authors:  Katri Sääksjärvi; Paul Knekt; Satu Männistö; Jukka Lyytinen; Markku Heliövaara
Journal:  Parkinsonism Relat Disord       Date:  2015-07-21       Impact factor: 4.891

8.  European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring.

Authors:  Gianfranco Parati; George Stergiou; Eoin O'Brien; Roland Asmar; Lawrence Beilin; Grzegorz Bilo; Denis Clement; Alejandro de la Sierra; Peter de Leeuw; Eamon Dolan; Robert Fagard; John Graves; Geoffrey A Head; Yutaka Imai; Kazuomi Kario; Empar Lurbe; Jean-Michel Mallion; Giuseppe Mancia; Thomas Mengden; Martin Myers; Gbenga Ogedegbe; Takayoshi Ohkubo; Stefano Omboni; Paolo Palatini; Josep Redon; Luis M Ruilope; Andrew Shennan; Jan A Staessen; Gert vanMontfrans; Paolo Verdecchia; Bernard Waeber; Jiguang Wang; Alberto Zanchetti; Yuqing Zhang
Journal:  J Hypertens       Date:  2014-07       Impact factor: 4.844

9.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

10.  Twenty-four hour non-invasive ambulatory blood pressure and heart rate monitoring in Parkinson's disease.

Authors:  Eva Stuebner; Ekawat Vichayanrat; David A Low; Christopher J Mathias; Stefan Isenmann; Carl-Albrecht Haensch
Journal:  Front Neurol       Date:  2013-05-15       Impact factor: 4.003

View more
  2 in total

1.  Impact of disease duration and cardiovascular dysautonomia on hypertension in Parkinson's disease.

Authors:  Davide L Vetrano; Maria S Pisciotta; Vincenzo Brandi; Maria R Lo Monaco; Alice Laudisio; Graziano Onder; Domenico Fusco; Paolo D L'Angiocola; Anna R Bentivoglio; Roberto Bernabei; Giuseppe Zuccalà
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-11-02       Impact factor: 3.738

2.  Untangling the relationship between fat distribution, nutritional status and Parkinson's disease severity.

Authors:  Maria S Pisciotta; Domenico Fusco; Giulia Grande; Vincenzo Brandi; Maria R Lo Monaco; Alice Laudisio; Graziano Onder; Anna R Bentivoglio; Diego Ricciardi; Roberto Bernabei; Giuseppe Zuccalà; Davide L Vetrano
Journal:  Aging Clin Exp Res       Date:  2019-03-15       Impact factor: 3.636

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.